VERSANT HCV Genotype 2.0 Products (LiPA)
Designed to identify and correctly detect multiple genotypes and subtypes
VERSANT® HCV Genotype 2.0 Products (LiPA) provide improved accuracy in identification of HCV genotype and subtype data for optimal patient therapy. Improve your efficiency with fully automated strip processing and an integrated system from amplification to interpretation.
* CE-marked in the EU. FDA-approved in the U.S.
The products/features (mentioned herein) are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens organization for further details.